- Home
- ANTX vs SYT Comparison
ANTX vs SYT Comparison
Compare ANTX & SYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- SYT
- Stock Information
- Founded
- ANTX 2017
- SYT 2010
- Country
- ANTX United States
- SYT Japan
- Employees
- ANTX N/A
- SYT N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- SYT Real Estate
- Sector
- ANTX Health Care
- SYT Finance
- Exchange
- ANTX Nasdaq
- SYT Nasdaq
- Market Cap
- ANTX 40.0M
- SYT 40.2M
- IPO Year
- ANTX 2022
- SYT 2023
- Fundamental
- Price
- ANTX $1.44
- SYT $1.90
- Analyst Decision
- ANTX Hold
- SYT
- Analyst Count
- ANTX 5
- SYT 0
- Target Price
- ANTX $3.50
- SYT N/A
- AVG Volume (30 Days)
- ANTX 298.6K
- SYT 34.8K
- Earning Date
- ANTX 11-13-2024
- SYT 09-27-2024
- Dividend Yield
- ANTX N/A
- SYT 0.36%
- EPS Growth
- ANTX N/A
- SYT N/A
- EPS
- ANTX N/A
- SYT 0.08
- Revenue
- ANTX N/A
- SYT $149,124,408.00
- Revenue This Year
- ANTX N/A
- SYT N/A
- Revenue Next Year
- ANTX N/A
- SYT N/A
- P/E Ratio
- ANTX N/A
- SYT $24.72
- Revenue Growth
- ANTX N/A
- SYT 3.11
- 52 Week Low
- ANTX $0.87
- SYT $1.43
- 52 Week High
- ANTX $22.22
- SYT $8.74
- Technical
- Relative Strength Index (RSI)
- ANTX 56.85
- SYT 55.26
- Support Level
- ANTX $1.23
- SYT $1.68
- Resistance Level
- ANTX $1.43
- SYT $2.05
- Average True Range (ATR)
- ANTX 0.09
- SYT 0.26
- MACD
- ANTX -0.01
- SYT 0.02
- Stochastic Oscillator
- ANTX 58.33
- SYT 59.61
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
About SYT SYLA Technologies Co. Ltd.
SYLA Technologies Co Ltd is a property technology company. It provides asset management platform systems that facilitate real estate crowd-funding as well as the purchase and sale of real estate.